Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Natural History Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)

NCT03227042 is registered in ClinicalTrials.gov with Allievex Corporation as lead sponsor.

NCT NCT03227042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03227042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Natural History Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)
Lead sponsor
Allievex Corporation
Phase
Observational
Overall status
Unknown status
Start date
November 16, 2017
Completion date
December 31, 2025
Enrollment
44 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

mucopolysaccharidosis type iiib